These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 28151845)
21. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. McAuley J; Boyer KM; Patel D; Mets M; Swisher C; Roizen N; Wolters C; Stein L; Stein M; Schey W Clin Infect Dis; 1994 Jan; 18(1):38-72. PubMed ID: 8054436 [TBL] [Abstract][Full Text] [Related]
22. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Petersen E; Schmidt DR Expert Rev Anti Infect Ther; 2003 Jun; 1(1):175-82. PubMed ID: 15482110 [TBL] [Abstract][Full Text] [Related]
24. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. Guerina NG; Hsu HW; Meissner HC; Maguire JH; Lynfield R; Stechenberg B; Abroms I; Pasternack MS; Hoff R; Eaton RB N Engl J Med; 1994 Jun; 330(26):1858-63. PubMed ID: 7818637 [TBL] [Abstract][Full Text] [Related]
25. [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy]. Wirden M; Botterel F; Romand S; Ithier G; Bourée P J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):566-7. PubMed ID: 10598352 [TBL] [Abstract][Full Text] [Related]
26. [Analysis of a case of severe congenital toxoplasmosis]. Pujol-Riqué M; Gómez-López L; Tudó G; Falgueras T; Costa J; Rodríguez-Miguélez JM; Coll O; Valls ME Med Clin (Barc); 1999 Nov; 113(18):701-3. PubMed ID: 10650573 [TBL] [Abstract][Full Text] [Related]
27. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Gras L; Gilbert RE; Ades AE; Dunn DT Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335 [TBL] [Abstract][Full Text] [Related]
31. [Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?]. Genuini M; Freihuber C; Girard I; de Montgolfier I; Kieffer F; Mitanchez D Arch Pediatr; 2011 Oct; 18(10):1084-6. PubMed ID: 21885264 [TBL] [Abstract][Full Text] [Related]
32. Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis. Chêne G; Thiébaut R Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):299-304. PubMed ID: 19430657 [TBL] [Abstract][Full Text] [Related]
33. Congenital toxoplasmosis in the state of Minas Gerais, Brazil: a neglected infectious disease? Carellos EV; Caiaffa WT; Andrade GM; Abreu MN; Januário JN; Epidemiol Infect; 2014 Mar; 142(3):644-55. PubMed ID: 23823156 [TBL] [Abstract][Full Text] [Related]
34. [Effects of combined treatment of infantile toxoplasmosis with pyrimethamine (daraprim) and sulfonamides on the blood and bone marrow]. Weissbach G Z Arztl Fortbild (Jena); 1965 Jan; 59(1):10-22. PubMed ID: 5885819 [No Abstract] [Full Text] [Related]
35. [Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches]. Pohl-Schickinger A; Feiterna-Sperling C; Weizsäcker K; Bührer C Z Geburtshilfe Neonatol; 2012 Apr; 216(2):73-6. PubMed ID: 22517047 [TBL] [Abstract][Full Text] [Related]
37. Congenital toxoplasmosis in a neonate with significant neurologic manifestations. Chuang YC; Chen JY; Ji DD; Su PH J Formos Med Assoc; 2012 Apr; 111(4):232-3. PubMed ID: 22526213 [No Abstract] [Full Text] [Related]
38. Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review. Ben-Harari RR; Goodwin E; Casoy J Drugs R D; 2017 Dec; 17(4):523-544. PubMed ID: 28879584 [TBL] [Abstract][Full Text] [Related]
39. Toxoplasmosis in pregnancy and its transmission to the fetus. Desmonts G; Couvreur J Bull N Y Acad Med; 1974 Feb; 50(2):146-59. PubMed ID: 4521728 [No Abstract] [Full Text] [Related]